We are live on
!
Find out more
FP
Factorial Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
25.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.79%
1 Year Est. Return
+25.59%
3 Year Est. Return
+78.35%
5 Year Est. Return
+78.52%
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$2.35M
(+2.1%)
Cap. Flow
-$1.16M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
117
New
18
Increased
22
Reduced
33
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3M |
| 2 |
Franklin Resources
BEN
|
+$2.65M |
| 3 |
J.M. Smucker
SJM
|
+$1.94M |
| 4 |
Perrigo
PRGO
|
+$1.36M |
| 5 |
nVent Electric
NVT
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.92M |
| 2 |
AstraZeneca
AZN
|
+$1.26M |
| 3 |
White Mountains Insurance
WTM
|
+$1.17M |
| 4 |
ALOG
Analogic Corp
ALOG
|
+$1.02M |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$992K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.08% |
| 2 | Healthcare | 20.71% |
| 3 | Industrials | 14.57% |
| 4 | Technology | 8.98% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tenet Healthcare
THC
$21.1B
| $1.47M | 1.32% |
43,900
-3,200
| -7% | -$99.5K |
|
|
27
Perrigo
PRGO
$1.43B
| $1.28M | 1.15% |
+17,600
| New | +$1.36M |
|
28
TechnipFMC
FTI
$30B
| $1.17M | 1.04% |
49,459
-15,053
| -23% | -$359K |
|
|
29
nVent Electric
NVT
$23.7B
| $1.15M | 1.03% |
+46,000
| New | +$1.2M |
|
|
LPNT
30
DELISTED
LifePoint Health, Inc.
LPNT
| $1.15M | 1.03% |
23,500
-13,300
| -36% | -$689K |
|
|
DFS
31
DELISTED
Discover Financial Services
DFS
| $1.11M | 0.99% |
15,700
+1,000
| +7% | +$73.3K |
|
|
32
White Mountains Insurance
WTM
$5.42B
| $1.09M | 0.97% |
1,197
-1,323
| -53% | -$1.17M |
|
|
KSU
33
DELISTED
Kansas City Southern
KSU
| $1.06M | 0.95% |
+10,000
| New | +$1.09M |
|
34
B&G Foods
BGS
$291M
| $1.05M | 0.94% |
35,200
-27,000
| -43% | -$725K |
|
|
MNK
35
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $996K | 0.89% |
53,400
+10,000
| +23% | +$159K |
|
36
Vanguard S&P 500 Value ETF
VOOV
$6.6B
| $966K | 0.86% |
+9,100
| New | +$972K |
|
37
V2X
VVX
$2.65B
| $960K | 0.86% |
31,155
+5,000
| +19% | +$169K |
|
38
Gen Digital
GEN
$16.2B
| $956K | 0.85% |
+46,300
| New | +$1.11M |
|
39
AAR Corp
AIR
$5.33B
| $955K | 0.85% |
20,543
-3,100
| -13% | -$141K |
|
|
IVC
40
DELISTED
Invacare Corporation
IVC
| $949K | 0.85% |
51,029
| – | – |
|
41
Phibro Animal Health
PAHC
$1.42B
| $944K | 0.84% |
20,500
-6,400
| -24% | -$283K |
|
42
OneSpan
OSPN
$567M
| $912K | 0.82% |
46,400
-27,100
| -37% | -$488K |
|
43
Red Robin
RRGB
$134M
| $909K | 0.81% |
19,500
+1,200
| +7% | +$68K |
|
44
Newell Brands
NWL
$2.24B
| $903K | 0.81% |
+35,000
| New | +$911K |
|
|
WDR
45
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $899K | 0.8% |
50,000
| – | – |
|
|
RDC
46
DELISTED
Rowan Companies Plc
RDC
| $892K | 0.8% |
55,000
+1,000
| +2% | +$15K |
|
47
Lantheus
LNTH
$6.99B
| $886K | 0.79% |
+60,900
| New | +$937K |
|
|
AAMI
48
Acadian Asset Management
AAMI
$2.93B
| $884K | 0.79% |
62,000
+38,000
| +158% | +$582K |
|
49
Vistra
VST
$52.8B
| $875K | 0.78% |
37,000
-39,000
| -51% | -$897K |
|
50
SiriusPoint
SPNT
$3.01B
| $875K | 0.78% |
70,000
+6,000
| +9% | +$80.2K |
|
Similar funds
TC
PBRA
DFS
LPAM
CI
ACA
LIA
CW
Factorial Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Factorial Partners held 117 positions worth $112M, up 2.1% from $110M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Factorial Partners's Q2 2018 filing shows 18 new, 22 increased, 33 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,500 shares worth $3.07M. The largest sale was Merck, an estimated $1.92M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Factorial Partners's largest Q2 2018 buy was Bristol-Myers Squibb: 55,500 shares worth $3.07M.
- Factorial Partners added most to Gilead Sciences in Q2 2018, an estimated $1.07M increase.
- Factorial Partners's biggest Q2 2018 reduction was White Mountains Insurance, cutting an estimated $1.17M.
- Factorial Partners fully exited Merck in Q2 2018, selling an estimated $1.92M.
- Factorial Partners's ten largest holdings make up 29% of its $112M portfolio in Q2 2018.
- Factorial Partners opened 18 new positions and closed 19 in Q2 2018.
- Factorial Partners's portfolio value rose 2.1% quarter-over-quarter to $112M.
Based on Factorial Partners's 13F filing for Q2 2018, filed 1 Aug 2018.